Stage IIIB Breast Cancer Completed Phase 2 Trials for Letrozole (DB01006)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01194440Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal SymptomsSupportive Care
NCT00416715Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast CancerSupportive Care